What's new

Everything that changed here, newest first: research, patents, portfolio works, books, and the site itself.

September 2026

  • NewResearch & IP

    Unknown is red

    If nobody can show that a control works, score it as failing. Amber and blank let an untested control sit quietly beside a tested one.

    Read more

  • NewResearch & IP

    What a findings dashboard leaves out

    Counting open findings measures the discovery process. It says nothing about detection speed, containment, or recovery, and it falls when scanning stops.

    Read more

  • NewResearch & IP

    What happens if the vendor is the one compromised?

    Third-party risk programs assess whether a vendor protects your data. They rarely assess the blast radius of the vendor's own access to your systems.

    Read more

  • NewResearch & IP

    Continuous traceability instead of reconstruction

    The chain from clinical need to post-market observation should be current every day, not rebuilt in the weeks before a submission or an audit. Reconstruction is where the errors enter.

    Read more

  • NewResearch & IP

    Decisions, Not Alerts

    One ranked stream of judgment calls, each carrying a recommendation, calibrated confidence, reasoning, evidence, the policy in force, the downside if wrong, the alternatives considered, a deadline and the role required to authorize it.

    Read more

  • NewResearch & IP

    Evidence as the Product

    A flight recorder for every recommendation and action: what happened, who initiated it, what data was used, which policy and model version were in force, what a human changed on review, and whether it was later judged helpful, neutral or harmful.

    Read more

  • NewResearch & IP

    Graduated Autonomy

    Autonomy is granted per workflow across four levels, from observe to operate within policy, against measured shadow-mode agreement, with drift monitoring and a rollback path. A single global autonomy score is unsafe.

    Read more

  • NewResearch & IP

    Migrating Off an Incumbent

    Import, reconcile, parallel run, readiness score. What cannot be reconciled is listed individually rather than rounded away, and shadow-mode disagreement clusters reveal where the operation is unready before anyone cuts over.

    Read more

  • NewResearch & IP

    Month-End Is an Evidence Problem

    Billing readiness presented exception-first: what is ready, what is blocked and why, what conflicts with policy, and what is documented but should not be billed. The system never asserts final eligibility and never submits a claim.

    Read more

  • NewResearch & IP

    Populations Without Tables

    Clustered groups of patients and a conversational explorer replace the filter-and-sort grid. Patients are grouped by what they need operationally, and the grouping itself can be interrogated.

    Read more

  • NewResearch & IP

    Regulatory execution as an AI workforce

    The regulated development system, described as work rather than paperwork: research, drafting, traceability, orchestration, evidence management, and audit support, with qualified professionals holding every judgment and approval.

    Read more

  • NewResearch & IP

    Reimbursement-first device discovery

    Find the reimbursed problem before designing anything. Coverage, coding, payment, and utilization are public, so whether anyone will pay is a research question with a documented answer, not a bet taken after two years of engineering.

    Read more

  • NewResearch & IP

    Simulation as an Operating Surface

    Enrollment changes, staff departures, program shifts, cadence and threshold changes and autonomy increases are run against the operation before they are made, with assumptions, uncertainty and risks shown rather than a single number.

    Read more

  • NewResearch & IP

    The Briefing as Home Screen

    The home screen is a narrative of what changed since the last review: what the system handled, what failed, ranked developments, one intervention worth making, and an evidence link on every claim.

    Read more

  • NewResearch & IP

    The commodity component assumption

    Do not design bespoke electronics unless a commodity part is demonstrably inadequate for the claim being made. The burden of proof sits with the custom design, the same way Zero Neo puts it on new software.

    Read more

  • NewResearch & IP

    The Dashboard Is a Symptom

    Tile walls, module sidebars and worklists are the visible residue of software that could not reason. Zero dashboard is not a visual preference; it is what an interface looks like once the ranking moves inside the system.

    Read more

  • NewResearch & IP

    The Executive Narrative Without KPI Tiles

    Leadership reporting written as prose that states the causal claim, with measures, believed drivers and confidence in support, and an explicit section on what remains unknown.

    Read more

  • NewResearch & IP

    The Labor Curve

    A rules-based operation has no mechanism to break the link between panel size and headcount. An AI-native one does, but the first two quarters of a migration cost more, not less, and the curve only bends where shadow-mode agreement supports widening autonomy.

    Read more

  • NewResearch & IP

    The Patient Story Replaces the Chart Page

    A narrative generated around the question currently being asked, with timeline lanes that draw missing data as missing, and explicit reasoning about which care program actually fits.

    Read more

  • NewResearch & IP

    The phone is part of the device

    Architectures where a smartphone or wearable is a component of the medical device, not a companion screen. It removes hardware and adds obligations, and the trade is only worth making with both sides written down.

    Read more